In vitro bone biocompatibility of poly(anhydride‐co‐imides) containing pyromellitylimidoalanine
- 1 May 1996
- journal article
- research article
- Published by Wiley in Journal of Orthopaedic Research
- Vol. 14 (3) , 445-454
- https://doi.org/10.1002/jor.1100140315
Abstract
Poly(anhydride‐co‐imides) are currently under study for applications involving bone. The cytotoxicity of a series of poly(anhydride‐co‐imides) with osteoblast‐like cells (MC3T3‐E1) was evaluated. The imide component of the copolymers was based on pyromellitylimidoalanine and the anhydride component was based on either sebacic acid or 1,6‐bis(carboxyphenoxy)hexane. Cell adhesion and proliferation on the surfaces of the polymer discs were observed by environmental scanning electron microscopy. During the first 24 hours of attachment, the cells showed normal morphology when cultured on copolymers containing 1,6‐bis(carboxyphenoxy)hexane. The cells did not adhere to the polymers containing sebacic acid, probably due to the rapid degradation of the polymer surfaces. Concurrently, the effects of polymer breakdown products on osteoblast‐like cells were evaluated by studying their proliferation (cell numbers), viability (dye exclusion), morphology (light microscopy), and phenotypic expression. The morphology of osteoblast‐like cells cultured in the presence of the polymer breakdown products pyromellitylimidoalanine and pyromellitic acid was found to be similar to that of the same cells grown on tissue culture polystyrene and consisted of a characteristic polygonal shape. With use of a monoclonal antibody to osteocalcin, these cells were shown to demonstrate preserved osteoblast phenotype with growth over a 21‐day period. In addition, the cells reached confluency after 3–4 days, similar to cells grown on tissue culture polystyrene. This in vitro evaluation showed that the poly(anhydride‐co‐imides) evaluated are non‐cytotoxic and may be viable biomaterials for orthopaedic applications.Keywords
This publication has 20 references indexed in Scilit:
- Cytotoxicity testing of poly(anhydride‐co‐imides) for orthopedic applicationsJournal of Biomedical Materials Research, 1995
- Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomasThe Lancet, 1995
- Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomasJournal of Neurosurgery, 1991
- Development of a new system for evaluating the biocompatibility of implant materials using an osteogenic cell line (MC3T3‐E1)Journal of Biomedical Materials Research, 1988
- Establishment of a clonal osteogenic cell line from newborn mouse calvariaJapanese Journal of Oral Biology, 1981
- Biodegradable ceramic implants in boneOral Surgery, Oral Medicine, Oral Pathology, 1971
- Tissue reaction to intrabony ceramic implantsOral Surgery, Oral Medicine, Oral Pathology, 1971
- Toxicologic aspects of implantsJournal of Biomedical Materials Research, 1967
- Responses of Epithelial-like Cells in Tissue Culture to Implant MaterialsJournal of Dental Research, 1967
- REACTION OF BONE TO VARIOUS METALSArchives of Surgery, 1924